Show simple item record

dc.contributor.authorDessalegn, Muluken
dc.contributor.authorDaniel, Ermias
dc.contributor.authorBehailu, Sileshi
dc.contributor.authorWagnew, Maereg
dc.contributor.authorNyagero, Josephat
dc.date.accessioned2021-08-24T10:39:30Z
dc.date.available2021-08-24T10:39:30Z
dc.date.issued11/26/2016
dc.identifier.citationThe Pan African Medical Journal. 2016;25 (Supp 2):5.en_US
dc.identifier.issn1937-8688
dc.identifier.urihttp://repository.amref.org/handle/123456789/128
dc.description© Muluken Dessalegn et al. The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en_US
dc.description.abstractIntroduction: the emergence of multi-drug resistant tuberculosis (MDR-TB) has become a major public health concern that threatens advances made in global TB control efforts. Though the problem is prevalent, it did not receive major attention to generate supportive evidence for the prevention and control of MDR-TB. The aim of this study was to identify predictors of MDR-TB in a national TB referral centre in Ethiopia. Methods: an unmatched, case-control study was conducted at St. Peter Hospital to assess risk factors associated with MDR-TB. The study included 103 culture proven, MDR-TB patients referred to the hospital during the study period (cases) and 103 randomly-selected TB patients with confirmed TB who turned negative after treatment (controls). Regressions analyses were used to determine the association of variables. Results: the mean age among cases and controls was 30.5 (±9.26) and 34.73 (±11.28) years, respectively. The likelihood of having MDR-TB was 20.3 times higher among those who had a any previous history of TB treatment (AOR=20.3 [CI 5.13, 80.58]), 15.7 times higher among those who had TB more than once (AOR=15.7 [CI 4.18, 58.71]) compared those who had once, 6.8 times higher among those who had pulmonary TB (AOR=6.8 [CI 1.16, 40.17]) and 16.1 times higher for those who had experienced treatment with a Category II regimen (AOR=16.1 [CI 2.40, 108.56]). HIV infection was less common among cases than controls. Conclusion: this study concluded that special attention should be given to patients with a history of the following: TB more than once, presence of pulmonary TB, and used a Category II treatment regimen, as these were all determining factors for MDR-TB. Thus, this study urges the development and implementation of well-planned and integrated strategies for MDR-TB control and prevention in Ethiopia.en_US
dc.description.sponsorshipAfrican Medical Research Foundationen_US
dc.language.isoenen_US
dc.publisherPan African Medical Journalen_US
dc.relation.ispartofseriesStrengthening health systems in communities: the experiences of AMREF Health Africa;Supp. 2: 5
dc.subjectMDR-TBen_US
dc.subjectPredictorsen_US
dc.subjectAdultsen_US
dc.subjectEthiopiaen_US
dc.subjectHIVen_US
dc.subjectTuberculosisen_US
dc.titlePredictors of Multidrug Resistant Tuberculosis Among Adult Patients at Saint Peter Hospital Addis Ababa, Ethiopiaen_US
dc.typeArticle, Journalen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

  • General - GEN [353]
    This is a collection of research papers from the wider Amref community

Show simple item record